157 related articles for article (PubMed ID: 1786479)
1. Human drug abuse liability: testing times ahead.
Camí J
Br J Addict; 1991 Dec; 86(12):1525-6. PubMed ID: 1786479
[No Abstract] [Full Text] [Related]
2. Barcelona meeting on clinical testing of drug abuse liability: consensus statement and recommendations.
Br J Addict; 1991 Dec; 86(12):1527-8. PubMed ID: 1786481
[No Abstract] [Full Text] [Related]
3. Perspectives and future on testing for abuse liability in humans.
Camí J
Br J Addict; 1991 Dec; 86(12):1529-31. PubMed ID: 1786482
[TBL] [Abstract][Full Text] [Related]
4. Assessing abuse liability during drug development: changing standards and expectations.
Schoedel KA; Sellers EM
Clin Pharmacol Ther; 2008 Apr; 83(4):622-6. PubMed ID: 18212799
[TBL] [Abstract][Full Text] [Related]
5. Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.
Woods JH
Drug Alcohol Depend; 1990 Apr; 25(2):229-33. PubMed ID: 1970287
[No Abstract] [Full Text] [Related]
6. Regulation and abuse liability testing of medicines in Europe beyond 1992.
García Alonso F
Br J Addict; 1991 Dec; 86(12):1533-6. PubMed ID: 1786483
[TBL] [Abstract][Full Text] [Related]
7. The necessity and utility of abuse liability evaluations in human subjects.
Vocci FJ
Br J Addict; 1991 Dec; 86(12):1537-42. PubMed ID: 1786484
[TBL] [Abstract][Full Text] [Related]
8. Guidelines and methodological reviews concerning drug abuse liability assessment.
Balster RL; Bigelow GE
Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S13-40. PubMed ID: 12759195
[TBL] [Abstract][Full Text] [Related]
9. A caveat: drug policy as factor of trends in trade and use of different substances.
Arnao G
Int J Addict; 1990 Dec; 25(12):1485-8. PubMed ID: 2094686
[No Abstract] [Full Text] [Related]
10. The 1993 distinguished lecturer in substance abuse.
Rosenthal MS
J Subst Abuse Treat; 1994; 11(1):3-7. PubMed ID: 8201631
[No Abstract] [Full Text] [Related]
11. [Legal medicine aspects of current abuse potential].
Kauert G; Eisenmenger W
Versicherungsmedizin; 1993 Feb; 45(1):15-7. PubMed ID: 8438535
[TBL] [Abstract][Full Text] [Related]
12. [German drug policy also successful in European comparison].
Kinderkrankenschwester; 2003 Jan; 22(1):6-7. PubMed ID: 15984429
[No Abstract] [Full Text] [Related]
13. Protection of participants and experimental design in clinical abuse liability testing.
Mendelson JH
Br J Addict; 1991 Dec; 86(12):1543-8. PubMed ID: 1786485
[TBL] [Abstract][Full Text] [Related]
14. Drug abuse in America: medical and socio-legal dilemmas.
Garcia SA
Med Law; 1992; 11(5-6):323-35. PubMed ID: 1484457
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of the narcotic drugs and psychotropic substances (amendment) act, 2014.
Mohapatra S; Rath N
Asian J Psychiatr; 2015 Apr; 14():80-1. PubMed ID: 25838083
[No Abstract] [Full Text] [Related]
16. The European Community of twelve and the drug demand. Excerpt of a comparative study of legislations and judicial practice.
Leroy B
Drug Alcohol Depend; 1992 Feb; 29(3):269-81. PubMed ID: 1559434
[TBL] [Abstract][Full Text] [Related]
17. [From an illegal drug (so-called non-medically used psychoactive drug) to the designated substance (Shitei-yakubutsu) controlled by the Pharmaceutical Affairs Law in Japan--approach from the laboratory examination to the regulation].
Satoh K; Kojima T
Yakugaku Zasshi; 2013; 133(1):1-2. PubMed ID: 23292011
[No Abstract] [Full Text] [Related]
18. Prescription drug abuse does not discriminate.
Lovedale L
Colo Nurse; 2014 May; 114(2):7. PubMed ID: 25118430
[No Abstract] [Full Text] [Related]
19. [Recent initiatives of the European Union on the field of drug use and trafficking].
Salazar L
Ann Ist Super Sanita; 2002; 38(3):319-21. PubMed ID: 12645184
[TBL] [Abstract][Full Text] [Related]
20. Public policy statement on national drug policy. American Society of Addiction Medicine.
J Addict Dis; 1994; 13(4):231-4. PubMed ID: 7734471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
